Addition of Diagnostic Products, Research Data, Patents and Technology Complements Cardisio’s Platform for AI-Based Heart Health Frankfurt, Germany, January 31., 2022—Cardisio GmbH, developer of the world’s first non-invasive, highly accurate screening method for heart diseases, today announced the acquisition...